John E. Abele, Director at BOSTON SCIENTIFIC CORP (BSX), sold 75,000 shares at $6.13 ($459K) on 2010-07-20, disclosed to the SEC on 2010-07-22.
Scheduled sale ($459k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.10 | 25,000 | $153K | 33.2% |
| 2 | $6.13 | 50,000 | $307K | 66.8% |
| Total | $6.12 avg | 75,000 | $459K | 100% |
| Filing → |
| BSX | BUY | 2015-08-18 | $1.8M | — | Filing → |
| BSX | SELL | 2010-08-19 | $23K | — | Filing → |
| BSX | SELL | 2010-08-18 | $273K | — | Filing → |